Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Top Cited Papers
- 1 January 2008
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 7 (1) , 97-109
- https://doi.org/10.1016/s1474-4422(07)70327-7
Abstract
No abstract availableKeywords
This publication has 161 references indexed in Scilit:
- Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neuronsAnnals of Neurology, 2006
- Reproducible nigral cell loss after systemic proteasomal inhibitor administration to ratsAnnals of Neurology, 2006
- Lack of nigrostriatal pathology in a rat model of proteasome inhibitionAnnals of Neurology, 2006
- Proteasome inhibition and Parkinson's disease modelingAnnals of Neurology, 2006
- Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's diseaseAnnals of Neurology, 2004
- DJ‐1 has a role in antioxidative stress to prevent cell deathEMBO Reports, 2004
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003
- Sequence Analysis of the Entire Mitochondrial Genome in Parkinson's DiseaseBiochemical and Biophysical Research Communications, 2002
- Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine SystemNeuron, 2000
- Absence of the Mitochondrial A7237T Mutation in Parkinson′s DiseaseBiochemical and Biophysical Research Communications, 1995